Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Massimo Dominici(University of Modena and Reggio Emilia), Katarina Le Blanc(Karolinska Institutet), Ingo Mueller(University Children's Hospital Tübingen), Ineke Slaper‐Cortenbach(University Medical Center Utrecht), F. Marini(The University of Texas MD Anderson Cancer Center), Diane S. Krause(Yale University), R. Deans(Athersys (United States)), Armand Keating(Princess Margaret Cancer Centre), Darwin J. Prockop(Tulane University), Edwin M. Horwitz(St. Jude Children's Research Hospital)

Cytotherapy

January 1, 2006

10.1080/14653240600855905

Cited by 17,666

Abstract

Related Papers

Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies

Patricia A. Zuk, Min Zhu, Hiroshi Mizuno et al.|Tissue Engineering|2001|8k

Mesenchymal stem cells

Arnold I. Caplan|Journal of Orthopaedic Research®|1991|6.5k

RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrow

Yuehua Jiang, Balkrishna Jahagirdar, R. Lee Reinhardt et al.|Nature|2002|5.5k

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement

E.M. Horwitz, Katarina Le Blanc, Massimo Dominici et al.|Cytotherapy|2005|2k

Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow

David C. Colter, Reiner Class, Carla M. DiGirolamo et al.|Proceedings of the National Academy of Sciences|2000|980